Previous Page  10 / 14 Next Page
Information
Show Menu
Previous Page 10 / 14 Next Page
Page Background

Page 33

Notes:

conferenceseries

.com

Volume 4

Clinical Neuropsychology: Open Access

Neuropsychiatry 2018

August 27-28, 2018

August 27-28, 2018 Tokyo, Japan

8

th

Global Experts Meeting on

Advances in Neurology and Neuropsychiatry

Philip Anthony McMillan, ClinNeuropsychol 2018, Volume 3

DOI: 10.4172/2472-095X-C1-002

Integrated biochemical theory of delirium and experience with pharmacological reversal

Philip Anthony McMillan

Hull and East Yorkshire Hospitals NHS Trust, UK.

D

elirium is a significant problem in older hospital admissions, with worse clinical outcomes, prolonged hospital stay and

functional disability. This presentation will cover the clinical experience of managing these complex patients during their

hospital stay. The basis of this theory is with hepatic encephalopathy and the fact that all forms of delirium are clinically

consistent. Looking to explain the integrated theory of delirium based on brain glutamate and ammonia management. This will

demonstrate the biochemical aspects of delirium and how it is related to other conditions and most significantly how there is a

higher incidence of delirium in dementia. Anecdotal experience of reversing delirium using this biochemical framework and

use of simple medication in hospital has been very successful with up to 70% of patients demonstrating clinical improvement.

This theory has the potential to revolutionize our care of older patients and give insight into the links between delirium and

dementia.

Biography

Philip Anthony McMillan is a Consultant in the NHS as a Medical Expert. His primary focus has been around geriatrics and neurological rehabilitation and has

developed unique perspectives on the capacity of the brain to recover from injuries and disease. Through international collaboration he has proposed a nutritional

protocol for dementia reversal and has recently had a breakthrough theory on the pathology of dementia. His current aim is to lead the field of dementia to a new

direction of research and treatment of this devastating disease.

philip.mcmillan@nhs.net